Blackstone Inc Praxis Precision Medicines, Inc. Transaction History

Blackstone Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.8 - $4.98 $3.07 Million - $19.1 Million	-3,840,000 Reduced 78.46%	1,054,109 $853,000
Q4 2021 Feb 14, 2022	SELL	$16.76 - $22.99 $7.48 Million - $10.3 Million	-446,546 Reduced 8.36%	4,894,109 $96.4 Million
Q3 2021 Nov 16, 2021	SELL	$13.15 - $22.56 $6.06 Million - $10.4 Million	-460,832 Reduced 7.94%	5,340,655 $98.7 Million
Q2 2021 Aug 16, 2021	SELL	$18.28 - $33.05 $49.4 Million - $89.2 Million	-2,700,000 Reduced 31.76%	5,801,487 $106 Million
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $232 Million - $475 Million	8,501,487 New	8,501,487 $468 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.02B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.